I posted earlier on preclinical findings that our growth factor drug (human FGF-1) can regenerate new dopamine-secreting neurons in a primate model of PD. This led to a significant improvement in motor skill functioning of the monkeys. I would now like to share data with you that FGF-1 can also decrease levels of the toxic aggregated alpha-synuclein protein, which is a hallmark of PD in humans.
In the figure below you can see brain slices through the substantia nigra region in an experimental animal model of Parkinson's disease. In the middle panel you can see the strands of aggregated synuclein which are known to be toxic to surrounding neurons. In the far right panel you can see the same area of the brain after two weeks of daily IV treatment with FGF-1 with a clearly visible decrease in synuclein tangles.
We believe we are attacking the two root causes of PD with our drug therapy, namely, by regenerating functional dopamine-secreting neurons as well as elimination of toxic aggregates of the alpha-synuclein protein.
Please follow us as we move into our clinical trials with this promising drug candidate.
Written by
j2jacobs
To view profiles and participate in discussions please or .
So far, so good with cancer worries. In toxicity studies in animals at 100-fold higher doses than will be used in the PD study we saw no carcinogenicity. Also, we have been in humans for a coronary artery disease indication and followed serum tumor markers very carefully and saw no increases.
JACOBS THANK YOU VER YMUCH FOR YOUR ANSWER ..YESTERDAY I TRIED T O ASK FOR THE TRIALS ......... I NEED MORE INFORMATION ABOUT THE NAME OF THE DOCTOR WHO WILL BE IN FRONT OF PROJECT HERE AND THE DEPARTAMENT IN CHARGE AND DATE PLEASE ALLL INFORMATION ................I WANTT O BE THERE
We should be starting in Mexico later this summer. We submitted the same PD application to both the US and Mexican regulatory authorities and the US said do another animal study and Mexico gave us the green light to start in PD patients.
That sounds good. I have PD and want this to work and be available by the weekend. If you want to do a trial in Europe...But even if you start your phase 1 in August it will be March 2022 before you publish results. Then phase 2 and then phase 3, then Mexican approval then the FDA approval based on that. If covid doesn't disrupt again. I can't see my neurologist being able to prescribe for me in much less than 7 years.
Unfortunately I don’t think this would work for me or others with parkinsonism. For now I will stick with high dose thiamine therapy. At least I know it helps me. This is very interesting. Is the FGF-1 human growth hormone? If not, what is it?
The protein we are developing his fibroblast growth factor 1 (FGF-1) which is part of the 22 member FGF family. No structural similarities to human growth hormone.
That is a great idea and in fact there is a San Diego company that is developing a shortened form of FGF-1 for diabetes. Unfortunately, the shortened form is good for diabetes, but lousy at growing new blood vessels, which is what we want.
"“Over the last three years, we have continually uncovered data which strengthens our theory that Therapeutic Angiogenesis might be a viable breakthrough treatment for Parkinson’s disease,” Daniel C. Montano, ZGM’s CEO, said..."
"Critically, FGF1 is a powerful stimulator of angiogenesis — but only in tissue that has been damaged or oxygen-starved."
so is every pwp's brain OXYGEN STARVED? very few get a MRI to assess brain blood flow.
Interesting! In another topic on this forum, there's a lot of interest being generated by a new study in Australia, which uses near-infrared light to penetrate into the brain:
To quote from a site that sells a product similar to the one used in the study: "The direct effect is very powerful. Red and near-infrared lights on the head result in better-functioning brain cells (neuroprotection), new brain cells being generated (neurogenesis), new blood vessels sprouting and bringing more oxygen to the cells (angiogenesis) and as well as acting to reduce inflammation. "
Very similar claims! I wonder if Zhittya is familiar with this therapy, and since it may well be years before FGF-1 is available to us, would this be a possible alternative available now?
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
There is a molecular link between Parkinson’s disease and melanoma
My Basic "Understanding" of PD Has Been Wrong
GREAT NEWS! Intra-Nasal FGF-1 Human Trials have started! WATCH video! Tremor reduced!
Is alpha synuclein aggregation an immune response? 
